GoodLifeSci

Bay Area Life Sciences Roundtable
2026-07-22 13:00 - 16:30 (America/Los_Angeles) | SFMOMA, 147 Minna St. Floor 5, San Francisco, CA, 94103, United States
Please join Sidley at SFMOMA for our annual Bay Area Life Sciences Roundtable, an afternoon of thoughtful and engaging discussions addressing cutting-edge trends and hot topics.

By Invitation Only. Space is limited. For questions, please contact sfevents@sidley.com.
Who may be interested in attending:
Executives, Directors, Investors, and In-House Counsel
CLE credit for this program is pending.

Swiss MedTech 2026 MedTech in Recalibration: Staying Ahead in Regulation, AI, and the Deal Landscape
2026-08-25 14:00 - 18:00 (Europe/Zurich) | Casino Bern, Casinoplatz 1, 3011, Bern, Switzerland
Sidley, ISS AG, and Swiss Medtech invite you to our annual Swiss MedTech afternoon, bringing together regulators, industry leaders, legal thought leaders, and scientific advisers to exchange insights on the evolving MedTech landscape.

RSVP here.

2026 is a pivotal year for Swiss and European MedTech. MDR and IVDR revisions are progressing, while the AI Act timeline for medical devices has been adjusted under the Digital Omnibus agreement.
At the same time, EU simplification initiatives are reshaping sustainability, digitalization, and reporting obligations.
Manufacturers also face growing geopolitical and economic pressures, including supply chain disruption, trade uncertainty, and rising costs.
In Switzerland, proposed Swissmedic supervisory fees, the TPITO revision and the rollout of swissdamed are adding further complexity, while increased M&A activity continues to reshape the sector.
Key highlights on the agenda include:
The European Regulatory Reset: Navigating MDR/IVDR Revision and Omnibus
What is changing, what is at stake, and how Swiss manufacturers should prepare for the next phase of the European regulatory framework.
Operational Resilience in a Volatile Market Environment
How trade tensions, supply chain dependencies, sustainability and PFAS-related requirements, and regulatory change are influencing manufacturing, sourcing, and long-term decisions.
Switzerland: Additional Economic Pressure on Manufacturers
Swissmedic supervisory fees, swissdamed implementation, proposed TPITO revisions, and evolving anti-corruption expectations — and what they mean for Swiss manufacturers.
AI Act: From Uncertainty to Implementation
The revised timeline for AI-enabled medical devices and the practical implications for MDSW strategy, data governance, and compliance planning.
Strategic Deals in MedTech
How AI, market access, supply chain resilience, and regulatory complexity are reshaping acquisition strategies, valuations, and investment decisions.
Who should attend?
Executives, investors, in-house counsel, and regulatory managers interested in and/or facing regulatory issues in Switzerland.
For more information or questions, please contact Geneva Events.

Sidley Healthcare Investment Conference 2026
2026-09-22 | The Francis Crick Institute, 1 Midland Road, London, NW1 1AT, UK, The Francis Crick Institute, 1 Midland Road, London, NW1 1AT, United Kingdom
As dealmaking and investment continue to shape the future of life sciences and healthcare, Sidley will convene senior leaders from pharma, biotech, healthcare, private equity, and venture capital to explore the forces defining the year ahead.

RSVP here.
Join Sidley and industry decision-makers from around the world for this one-day, in-person program in London, with a virtual attendance and networking option available for those joining from outside the UK.
Expect a day of sharp insights, dynamic discussion, and valuable networking as we explore how the continued convergence of innovation and capital is driving positive patient outcomes and investment returns.
View the Sidley Healthcare Investment Conference 2025 highlights.
